Skip to main content
SpringerLink
Log in

Improvements in pelvic exenteration: Factors responsible for reducing morbidity and mortality

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Since pelvic exenteration for the treatment of recurrent gynecologic malignancy first was described, reported rates of morbidity and mortality have declined steadily. However, the factors responsible for this decline have never been clearly delineated.

Methods: We reviewed the charts of 154 patients who underwent pelvic exenteration for gynecologic malignancy between 1954 and 1994. Charts were abstracted for details of the surgical procedure, pathologic findings, postoperative management, short- and long-term complications, time to recurrence, and overall survival.

Results: Seventy-two patients (47%) experienced 95 identifiable postoperative complications, resulting in death in 22 patients (14%). The rate of infectious complications declined to a statistically significant degree between the first two decades and latter two decades of the study (odds ratio [OR] 0.28, 95% CI 0.11–0.69). The use of routine prophylactic antibiotics was associated with this decline in infectious complications (OR 0.25, 95% CI 0.07–0.83). The use of preoperative subcutaneous heparin was associated with a reduction in thrombotic complications from 5 of 100 patients to 0 of 54 patients (P=.11), as well as a significant reduction in overall risk of complications (OR 0.53, 95% CI 0.33–0.85) and risk of postoperative mortality (OR 0.19, 95% CI 0.05–0.80). There was a significant reduction in overall risk of postoperative complications with both intensive care unit monitoring postoperatively (OR 0.65, 95% CI 0.43–0.99) and routine postoperative monitoring with a pulmonary artery catheter (OR 0.61, 95% CI 0.38–0.98).

Conclusions: Routine use of prophylactic antibiotics, prophylactic subcutaneous heparin, and intensive postoperative monitoring appear to have reduced morbidity from pelvic exenteration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma.Cancer 1948;1:177–83.

    Google Scholar 

  2. Brunschwig A, Daniel W. Pelvic exenteration operations: with summary of sixty-six cases surviving more than five years.Ann Surg 1960;151:571–6.

    CAS  PubMed  Google Scholar 

  3. Averette HE, Lichtinger M, Sevin B, Girtanner RE. Pelvic exenteration: a 15-year experience in a general metropolitan hospital.Am J Obstet Gynecol 1984;150:179–84.

    CAS  PubMed  Google Scholar 

  4. Symmonds RE, Pratt JH, Webb MJ. Exenterative operations: experience with 198 patients.Am J Obstet Gynecol 1975;121:907–18.

    CAS  PubMed  Google Scholar 

  5. Lawhead RA, Clark DGC, Smith DH, Pierce VK, Lewis JL. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience.Gynecol Oncol 1989;33:279–82.

    Article  PubMed  Google Scholar 

  6. Talledo OE. Pelvic exenteration—Medical College of Georgia experience.Gynecol Oncol 1985;22:181–8.

    Article  CAS  PubMed  Google Scholar 

  7. Rodriguez Cuevas H, Torres A, De La Garza M, Hernandez D, Herrera L. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases.J Surg Oncol 1988;38:121–5.

    CAS  PubMed  Google Scholar 

  8. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity.Gynecol Oncol 1989;35:93–8.

    Article  CAS  PubMed  Google Scholar 

  9. Inguilla W, Cosmi EV. Pelvic exenteration for advanced carcinoma of the cervix.Am J Obstet Gynecol 1967;99:1083–6.

    Google Scholar 

  10. Ketcham AS, Deckers PJ, Sugarbaker EV, Hoye RC, Thomas LB, Smith RR. Pelvic exenteration for carcinoma of the uterine cervix.Cancer 1970;26:513–21.

    CAS  PubMed  Google Scholar 

  11. Rutledge FN, Smith JP, Wharton JT, O'Quinn AG. Pelvic exenteration: analysis of 296 patients.Am J Obstet Gynecol 1977;129:881–92.

    CAS  PubMed  Google Scholar 

  12. Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.Obstet Gynecol 1989;73:1027–34.

    CAS  PubMed  Google Scholar 

  13. Morley GW, Lindenauer SM. Pelvic exenterative therapy for gynecologic malignancy.Cancer 1976;38:581–6.

    CAS  PubMed  Google Scholar 

  14. Finlayson CA, Eisenberg BL. Palliative pelvic exenteration: patient selection and results.Oncology 1996;10:479–90.

    CAS  PubMed  Google Scholar 

  15. Fuchtner C, Manetta A, Walker JL, Emma D, Berman M, DiSaia PJ. Radical hysterectomy in the elderly patient: analysis of morbidity.Am J Obstet Gynecol 1992;166:593–7.

    CAS  PubMed  Google Scholar 

  16. Shuster PA, Barter JF, Potkul RK, Barnes WA, Delgado G. Radical hysterectomy morbidity in relation to age.Obstet Gynecol 1991;78:77–9.

    CAS  PubMed  Google Scholar 

  17. Geisler JP, Geisler HE. Radical hysterectomy in patients 65 years of age and older.Gynecol Oncol 1994;53:208–11.

    CAS  PubMed  Google Scholar 

  18. Navon JD, Weinberg AC, Ahlering TE. Continent urinary diversion using a modified Indiana pouch in elderly patients.Am Surg 1994;60:786–8.

    CAS  PubMed  Google Scholar 

  19. Matthews CM, Morris M, Burke TW, Gershenson DM, Wharton JT, Rutledge FN. Pelvic exenteration in the elderly patient.Obstet Gynecol 1992;79:773–7.

    CAS  PubMed  Google Scholar 

  20. Curry SL, Nahhas WA, Jahshan AE, Whitney CW, Mortel R. Pelvic exenteration: a 7-year experience.Gynecol Oncol 1981;11:119–23.

    CAS  PubMed  Google Scholar 

  21. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy.Obstet Gynecol 1984;63:92–8.

    CAS  PubMed  Google Scholar 

  22. Kakkar VV, Corrigan TP, Fossard DP. Prevention of post-operative pulmonary embolism by low dose heparin.Lancet 1975;2:45–51.

    Google Scholar 

  23. Taberner DA, Poller L, Burslem RW, Jones JB. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.Br Med J 1978;1:272.

    CAS  PubMed  Google Scholar 

  24. Tanos V, Rojansky N. Prophylactic antibiotics in abdominal hysterectomy.J Am Coll Surg 1994;179:593–600.

    CAS  PubMed  Google Scholar 

  25. Angioli R, Sevin B, Penalver M, Steren A, Malinin T, Averette H. Pelvic floor reconstruction with dura mater allograft after pelvic exenteration.J Pelvic Surg 1996;2:58–62.

    Google Scholar 

  26. Bricker EM. The evolution of the ileal segment bladder substitution operation.Am J Surg 1978;135:834–41.

    Article  CAS  PubMed  Google Scholar 

  27. Gotsadze D, Charkviani L, Nemsadze G, Tsintsadze I, Pirtskhalaishvili G. Continent urinary diversion (Gotsadze pouch) after pelvic exenteration for gynecologic malignancies.Eur J Gynaecol Oncol 1994;15:369–71.

    CAS  PubMed  Google Scholar 

  28. Navon JD, Weinberg AC, Ahlering TE. Continent urinary diversion using a modified Indiana Pouch in elderly patients.Am Surg 1994;60:786–8.

    CAS  PubMed  Google Scholar 

  29. Eisner RF, Montz FJ, Berek JS. Cytoreductive surgery for advanced ovarian cancer: cardiovascular evaluation with pulmonary artery catheters.Gynecol Oncol 1990;37:311–14.

    Article  CAS  PubMed  Google Scholar 

  30. Naylor CD, Sibbald WJ, Sprung CL, Pinfold SP, Calvin JE, Cerra FB. Pulmonary artery catheterization: can there be an integrated strategy for guideline development and research promotion?JAMA 1993;269:2407–11.

    CAS  PubMed  Google Scholar 

  31. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients.Chest 1992;102:208–15.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York

    Jeffrey M. Goldberg MD, M. Steven Piver MD, Ronald E. Hempling MD, Christine Aiduk NP, Leslie Blumenson PhD & Fernando O. Recio MD

Authors
  1. Jeffrey M. Goldberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Steven Piver MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald E. Hempling MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine Aiduk NP
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leslie Blumenson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando O. Recio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldberg, J.M., Steven Piver, M., Hempling, R.E. et al. Improvements in pelvic exenteration: Factors responsible for reducing morbidity and mortality. Annals of Surgical Oncology 5, 399–406 (1998). https://doi.org/10.1007/BF02303857

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303857

Key Words

Search

Navigation